- Michael Roberts
- Health Editor, BBC
The film was released, Cambridge University Hospitals NHS Foundation Truss
British experts have confirmed that they have found a drug that can be used to help Covid-19 patients and greatly reduce their risk of death.
Experts say paracetamol is a combination drug used to treat “retinal” rheumatism.
Experimental results show that this drug reduces the risk of death by 20% in acute cov- eral patients admitted to the hospital.
The researchers pointed to the possibility of using this drug as a cheaper dexamethasone to save more lives.
The results also suggest that the drug could halve the number of deaths caused by Govit 19.
The National Health Safety Commission in the UK may recommend the use of paracetamol based on these scientific findings.
A course of treatment using pills of this drug can cost up to 250, although the Health Care Authority may negotiate to reduce the value.
To save lives
“I want to thank all the researchers, doctors and volunteers involved in this work,” said Sajid Javed, Britain’s Minister of Health and Social Welfare.
“Medical and scientific experts will review the results before making any decisions about the next stage,” he added.
Although vaccines play a major role in reducing the spread of the disease and saving lives, the infection is still prevalent in some people, including those suffering from severe fatigue caused by Govt.
The Recovery Foundation conducts tests on existing patients with Kovit to see if they can help with treatment.
In fact, dexamethasone, toxilisumab, and ronabrive have been found to alter medical practices in the treatment of corona virus worldwide, and experts claim that they are proud to have saved hundreds, if not millions, of lives.
Now this new combination, paracetamol, joins the list of indicated drugs because it greatly helps to improve the condition of many critically ill cov patients, including ventilators.
The results indicated that the benefits of this drug outweigh the many life-saving drugs used in the treatment of goiter.
“I was in the hospital for a month, mostly in the intensive care unit,” said Mark Rover, 51, from Cambridge, who took part in the drug trials.
“Everything in my body was like fighting everything,” he added.
He continued, “I received respiratory support almost all the time, and I got tuberculosis and pneumonia together in the lungs.”
“But I thought it was my duty to take part in the rescue trials because no matter what happened to me, I knew it was because I was doing something positive to help others,” Raver said.
“I am very pleased with the results of the paracetamol tests and hope it will be used for the benefit of many,” he added.
There are several medications currently used to treat goiter, including:
- Anti-inflammatory drugs that inhibit the immune system from over-activating the effects of infection and leading to death.
- Antiviral drugs make it harder for the corona virus to reproduce itself and multiply in the body.
- Treatment with antibodies that mimic the immune system in attacking the virus.
Martin Landrey, a professor of medicine and epidemiology at Oxford University’s School of Population Health, and one of the leaders of the research team overseeing the recovery trials, said: “Hospitalization for acute cases of covid disease is now well established.
He added, “Today’s results show that treatment with paracetinib not only increases the chances of survival from covit 19, but also provides additional benefit to drugs used to treat the virus, such as dexamethasone and tosilisumab, as it reduces the immune response to the virus.”
He continued, “This finding opens the door to the possibility of combining the use of more than one type of anti – inflammatory drug to reduce the risk of death in the most severe cases.”
“Award-winning beer geek. Extreme coffeeaholic. Introvert. Avid travel specialist. Hipster-friendly communicator.”
